Daishin Securities Raises Pan Ocean Target Price to ₩6,000 on Strong BDI Performance Despite Off-Season

COMPANY / Reporter Paul Lee / 2025-08-01 07:58:46

Photo courtesy of Yonhap News

 

 

[Alpha Biz= Paul Lee] SEOUL – Daishin Securities raised its target price for Pan Ocean from ₩5,000 to ₩6,000 on August 1, maintaining a “Buy” rating as the Baltic Dry Index (BDI) remains above 2,100 despite entering a traditionally weak season.



Analyst Yang Ji-hwan cited several drivers behind the unexpectedly strong freight index:

Increased shipping volumes from Australia and Brazil

Rising coal shipments due to higher power demand for cooling

Growth in China’s steel export volumes



“While long-term demand visibility remains uncertain, the fact that BDI levels remain high even in the off-season is noteworthy,” Yang said.

Daishin revised its H2 average BDI forecast from 1,530 to 1,800, reflecting continued market resilience.



Solid Q2 Performance
Thanks to the BDI’s surge, Pan Ocean reported strong second-quarter results:

Revenue: ₩1.29 trillion

Operating profit: ₩123 billion
(roughly in line with market consensus)



Yang noted that Pan Ocean’s LNG division delivered robust profitability supported by fleet expansion and long-term charter contracts. The dry bulk segment also improved profitability despite a smaller operating fleet, driven by favorable market conditions.

With freight rates holding strong, Daishin expects Pan Ocean to maintain earnings momentum into the second half of 2024.
 

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

Hanjin Group Moves Forward with Low-Cost Carrier (LCC) Consolidation Amid Financial Challenges
President Yoon Demands Strong Action on Coupang Data Breach During Ministry Reports
Fair Trade Commission Begins Review of Korean Air’s Guam Route Compliance Adjustment Request
Celltrion Executes KRW 782.4 Billion Capital Increase to Acquire Eli Lilly US Facility, Announces Record Dividends
GS Retail Employees Move to Establish Labor Union
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS